Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Jump To

Arazlo

  • Generic Name: tazarotene lotion
  • Brand Name: Arazlo
  • Drug Class: Acne Agents, Topical, Antipsoriatics, Topical, Retinoid-like Agents, Topical
Reviewed by Medsayfa.com Last updated June 15, 2024

Patient Information

ARAZLO
(ah-RAZ-low)
(tazarotene) lotion, for topical use

Important information: ARAZLO is for use on skin only. Do not use it in your eyes, mouth, the corners of your nose, or vagina.

What is the most important information I should know about ARAZLO?

ARAZLO may cause birth defects if used during pregnancy.

You must not be pregnant when you start using ARAZLO or become pregnant during treatment with ARAZLO.

  • For people who are able to get pregnant:
    • Your healthcare provider should order a pregnancy test for you within 2 weeks before you begin treatment with it to be sure that you are not pregnant. Your healthcare provider will decide when to do the test.
    • Begin treatment with it during a normal menstrual period.
    • Use an effective form of birth control (contraception) during treatment with it. Talk with your healthcare provider about birth control options that may be used to prevent pregnancy during treatment with it.
    • Stop using ARAZLO and tell your healthcare provider right away if you become pregnant during treatment with ARAZLO.

What is ARAZLO?

ARAZLO is a prescription medicine used on the skin (topical) to treat people 9 years of age and older with acne vulgaris. It is not known if it is safe and effective in children under 9 years of age.

Do not use ARAZLO if you are pregnant or plan to become pregnant. See, “What is the most important information I should know about it?” at the beginning of this leaflet.

Before using it, tell your healthcare provider about all your medical conditions, including if you:

  • have eczema or any other  skin problems
  • are breastfeeding or plan to breastfeed. It is not known if it passes into your breast milk. If you use it while breastfeeding, use it for the shortest time needed. Do not apply it directly to the nipple and the areola to avoid your child being exposed to the medicine.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Certain medicines, vitamins, or supplements may make your skin more sensitive to sunlight. Ask your healthcare provider for a list of medicines if you are not sure.

Especially tell your healthcare provider about any medicines (such as benzoyl peroxide) used on your skin or cosmetics you use, including moisturizers, creams, lotions, or products that can dry out your skin.

Know the medicines you take. Keep a list of them to show to your healthcare provider and pharmacist when you get a new medicine.

How should I use ARAZLO?

  • Use ARAZLO exactly as your healthcare provider tells you to use it.
  • Apply a thin layer of it to cover the affected areas 1 time each day.
  • If you use other medicines on your skin such as benzoyl peroxide during treatment with it, you should apply one in the morning and one in the evening to separate the application time.
  • Do not get it in your eyes, the corners of your nose, or in your mouth. If it gets in your eyes, rinse them well with water. Call your healthcare provider or get medical help if you have eye irritation that does not go away.
  • Wash your hands after applying it.

What should I avoid during treatment with ARAZLO?

  • Avoid sunlight, including sunlamps during treatment with it. ARAZLO can make you more sensitive to the sun, and the light from sunlamps and tanning beds. You could get severe sunburn. Use sunscreen and wear a widebrimmed hat and clothes that cover your skin if you have to be in sunlight.
  • Avoid using cosmetics or topical medicines that may make your skin more sensitive to sunlight or make your skin dry.
  • Avoid using it on skin with eczema or sunburned skin because it may cause severe irritation.

What are the possible side effects of ARAZLO?

ARAZLO may cause serious side effects, including:

  • See, “What is the most important information I should know about ARAZLO?”
  • Skin irritation. ARAZLO may cause application site skin pain, dryness, flaking or peeling, redness, and itching. Tell your healthcare provider if you develop any skin irritation during treatment with it. If you develop any of these symptoms, your healthcare provider may tell you to use a moisturizer, decrease the number of times you apply it, or completely stop treatment with it. Also, wind or cold weather may be more irritating to your skin during treatment with it.
  • Sensitivity to sunlight and risk of sunburn. See, “What should I avoid during treatment with ARAZLO?”

The most common side effects of ARAZLO include skin pain, dryness, peeling, redness, and itching.

These are not all the possible side effects of this.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

How should I store ARAZLO?

  • Store it at room temperature between 68°F to 77°F (20°C to 25°C).
  • Do not freeze.

Keep ARAZLO and all medicines out of the reach of children.

General information about the safe and effective use of ARAZLO.

Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use it for a condition for which it was not prescribed. Do not give it to other people, even if they have the same symptoms that you have. It may harm them. You can ask your pharmacist or healthcare provider for information about it that is written for health professionals.

What are the ingredients in ARAZLO?

Active ingredient: tazarotene

Inactive ingredients: carbomer copolymer type B, carbomer homopolymer type A, diethyl sebacate, edetate disodium dihydrate, light mineral oil, methylparaben, propylparaben, purified water, sodium hydroxide, sorbitan monooleate and sorbitol solution, 70%

This Patient Information has been approved by the U.S. Food and Drug Administration.

Read Next Article